{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:27:09Z","timestamp":1794090429647,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA260541"],"award-info":[{"award-number":["U01CA260541"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.127995","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:44:54Z","timestamp":1763617494000},"page":"127995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of the bivalent COVID-19 booster on spike-specific t cell responses"],"prefix":"10.1016","volume":"69","author":[{"given":"Amparo","family":"Mart\u00ednez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Isela","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.vaccine.2025.127995_bb0005","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127995_bb0010","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127995_bb0015","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127995_bb0020","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc2108829","article-title":"Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination","volume":"385","author":"Barouch","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127995_bb0025","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127995_bb0030","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127995_bb0035","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19","volume":"384","author":"Doria-Rose","year":"2021","journal-title":"N Engl J Med"},{"issue":"6572","key":"10.1016\/j.vaccine.2025.127995_bb0040","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"issue":"6561","key":"10.1016\/j.vaccine.2025.127995_bb0045","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"issue":"66","key":"10.1016\/j.vaccine.2025.127995_bb0050","doi-asserted-by":"crossref","first-page":"eabl5344","DOI":"10.1126\/sciimmunol.abl5344","article-title":"BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype","volume":"6","author":"Guerrera","year":"2021","journal-title":"Sci Immunol"},{"issue":"6566","key":"10.1016\/j.vaccine.2025.127995_bb0055","doi-asserted-by":"crossref","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"issue":"7901","key":"10.1016\/j.vaccine.2025.127995_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"7898","key":"10.1016\/j.vaccine.2025.127995_bb0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127995_bb0070","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMc2215471","article-title":"Effectiveness of bivalent boosters against severe omicron infection","volume":"388","author":"Lin","year":"2023","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.vaccine.2025.127995_bb0075","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2024.04.049","article-title":"A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against omicron variants","volume":"42","author":"Song","year":"2024","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127995_bb0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2213907","article-title":"Antibody response to omicron BA.4-BA.5 bivalent booster","volume":"388","author":"Wang","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127995_bb0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127995_bb0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127995_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00105-2","article-title":"Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage","volume":"4","author":"Traut","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2025.127995_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107271","article-title":"Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT\/BA.4-5 COVID-19 mRNA vaccine as the additional booster","volume":"149","author":"Tang","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127995_bb0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127995_bb0110","article-title":"SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire","volume":"5","author":"Tarke","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127995_bb0115","article-title":"Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4(+) T cell clonotypes","volume":"5","author":"Sop","year":"2024","journal-title":"Cell Rep Med"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127995_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.934","article-title":"The MegaPool approach to characterize adaptive CD4+ and CD8+ T cell responses","volume":"3","author":"da Silva Antunes","year":"2023","journal-title":"Curr Protoc"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127995_bb0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chom.2023.12.003","article-title":"Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant","volume":"32","author":"Nesamari","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127995_bb0130","doi-asserted-by":"crossref","first-page":"e0002703","DOI":"10.1371\/journal.pgph.0002703","article-title":"Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants","volume":"vol. 4","author":"Riou","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127995_bb0135","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127995_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115907","article-title":"Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters","volume":"44","author":"da Silva Antunes","year":"2025","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127995_bb0145","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127995_bb0150","article-title":"Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"issue":"6529","key":"10.1016\/j.vaccine.2025.127995_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127995_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127995_bb0165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","article-title":"Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19","volume":"183","author":"Su","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127995_bb0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chom.2022.02.003","article-title":"Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status","volume":"30","author":"Yu","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127995_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01316-23","article-title":"Antibody response to the BA.5 bivalent vaccine shot: a two-year follow-up study following initial COVID-19 mRNA vaccination","volume":"11","author":"Hirotsu","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127995_bb0180","article-title":"Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies. Lancet","volume":"4","author":"Carreno","year":"2023","journal-title":"Microbe"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127995_bb0185","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1056\/NEJMc2214314","article-title":"Substantial neutralization escape by SARS-CoV-2 omicron variants BQ.1.1 and XBB.1","volume":"388","author":"Miller","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127995_bb0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-immunol-101721-061120","article-title":"T cell responses to SARS-CoV-2","volume":"41","author":"Sette","year":"2023","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127995_bb0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41541-025-01129-6","article-title":"Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens","volume":"10","author":"Trieu","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127995_bb0200","article-title":"Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127995_bb0205","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"issue":"48","key":"10.1016\/j.vaccine.2025.127995_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127995_bb0215","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127995_bb0220","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202617","article-title":"Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection","volume":"218","author":"Le Bert","year":"2021","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127995_bb0225","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1038\/s41467-021-23333-3","article-title":"Peripheral and lung resident memory T cell responses against SARS-CoV-2","volume":"12","author":"Grau-Exposito","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127995_bb0230","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"issue":"62","key":"10.1016\/j.vaccine.2025.127995_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5021","article-title":"Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients","volume":"6","author":"Notarbartolo","year":"2021","journal-title":"Sci Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127995_bb0240","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","article-title":"Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease","volume":"54","author":"Bergamaschi","year":"2021","journal-title":"Immunity"},{"issue":"61","key":"10.1016\/j.vaccine.2025.127995_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5669","article-title":"CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients","volume":"6","author":"Mallajosyula","year":"2021","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127995_bb0250","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127995_bb0255","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1038\/s41467-024-47429-8","article-title":"SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4\/5 COVID-19-vaccination in previously infected and non-infected individuals","volume":"15","author":"Urschel","year":"2024","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:54:36Z","timestamp":1766076876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25012939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S0264410X25012939"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127995","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the bivalent COVID-19 booster on spike-specific t cell responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127995"}}